Audited Results of Windlas Biotech Ltd. Company

(Rs in Cr.)	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Operating Income	904.09	759.88	630.96	513.08	465.93
Manufacturing Expenses	28.29	21.61	16.15	12.90	11.01
Personnel Expenses	152.09	122.92	87.46	70.32	63.41
Selling Expenses	7.18	2.79	4.83	2.98	0
Administrative Expenses	54.59	46.59	48.24	41.20	35.80
Expenses Capitalised	0	0	0	0	0
Cost Of Sales	799.39	665.76	552.85	452.84	413.04
Operating Profit	104.69	94.11	78.10	60.24	52.90
Other Recurring Income	17.80	17.65	13.47	9.96	6.71
Adjusted PBDIT	122.50	111.76	91.57	70.21	59.60
Financial Expenses	4.83	4.38	1.10	0.79	1.42
Depreciation	30.74	27.98	13.44	12.36	12.15
Other Write offs	0	0	0	0	0
Adjusted PBT	86.93	79.39	77.02	57.06	46.04
Tax Charges	20.50	18.75	18.88	14.41	7.48
Adjusted PAT	66.44	60.65	58.14	42.64	38.56
Non Recurring Items	0.11	-0.54	-0.24	-0.16	-0.18
Other Non Cash adjustments	0	0	0	0	0
Reported Net Profit	66.44	60.65	58.14	42.64	38.56
Equity Dividend	12.16	11.49	8.32	7.63	7.63
Preference Dividend	0	0	0	0	0
Retained Earnings	329.29	274.90	226.29	176.70	134.22

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article